| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director | 10% Owner
5 companies
Crandell Keith is a 10% Owner at Sana Biotechnology, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 7 buys and 3 sells.
Estimated insider holdings value: $40.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2024 | BOLD Boundless Bio, Inc. | 10% Owner | Buy | 200,000 | $16.00 | $3,200,000.00 | +12.0% | -69.2% | -89.1% | |
| Feb 8, 2024 | SANA Sana Biotechnology, Inc. | 10% Owner | Buy | 1,818,181 | $5.50 | $9,999,995.50 | +5.4% | +54.1% | -51.5% | |
| Aug 12, 2021 | TWST Twist Bioscience Corp | Director | Sell | 45,000 | $107.01 | $4,815,377.39 | -22.5% | +11.1% | -50.5% | |
| Dec 22, 2020 | MASS 908 Devices Inc. | Director, 10% Owner | Buy | 300,000 | $20.00 | $6,000,000.00 | +5.5% | - | - | |
| Dec 11, 2017 | Director, 10% Owner | Buy | 266,000 | $15.00 | $3,990,000.00 | +20.9% | - | - |